Friday, August 8, 2008

Biotech Under Mass. Attack 

By Sally Pipes

Categories:  Massachusetts

(This op-ed appeared in Wednesday's Boston Herald.

On the last day of July, the Massachusetts Legislature passed the Act to Promote Cost Containment, Transparency and Efficiency in the Delivery of Quality Health Care. It’s both a mouthful and a mess. If Gov. Deval Patrick doesn’t veto the bill by Aug. 13, the law will put a needless chill on clinical research and pharmaceutical innovation in the commonwealth.

Among other provisions, the bill would require public disclosure when payments of $50 or more are made between pharmaceutical research firms and health-care providers. The information from these transactions - which includes physicians’ names - would be posted on the Internet.

Read the rest...



RSS feed

FEATURED BLOGGERS

John R. Graham
Pacific Research Institute
View Posts
Christie Raniszewski Herrera
American Legislative Exchange Council (ALEC)
View Posts
Paul Gessing
Rio Grande Foundation
View Posts
Michael Bond
National Center for Policy Analysis
View Posts
Tarren R. Bragdon
Maine Heritage Policy Center and Empire State Center
View Posts
Liberty is for me .
Blogivist
View Posts
Nathan Benefield
Commonwealth Foundation
View Posts
Greg Blankenship
Illinois Policy Institute
View Posts

MEDICAID POLICY EXCHANGE

Read more